Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / BMY - Idera's tilsotolimod shows positive effect in mid-stage melanoma study

BMY - Idera's tilsotolimod shows positive effect in mid-stage melanoma study

Bristol-Myers Squibb Company
  • Idera Pharmaceuticals (IDRA -2.4%) announces final results from a Phase 1/2 clinical trial, ILLUMINATE-204, evaluating Toll-like receptor 9 (TLR9) agonist tilsotolimod, combined with Bristol-Myers Squibb's (BMY -1.4%) Yervoy (ipilimumab), in metastatic melanoma patients.
  • More news on: Idera Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: Bristol-Myers Squibb Company
Stock Symbol: BMY
Market: NYSE
Website: bms.com
Menu
BMY BMY Quote BMY Short BMY News BMY Articles BMY Message Board
Get BMY Alerts

News, Short Squeeze, Breakout and More Instantly...